The Emperor's New Drugs: Exploding the Antidepressant MythBasic Books, 26 ene 2010 - 240 páginas Do antidepressants work? Of course -- everyone knows it. Like his colleagues, Irving Kirsch, a researcher and clinical psychologist, for years referred patients to psychiatrists to have their depression treated with drugs before deciding to investigate for himself just how effective the drugs actually were. Over the course of the past fifteen years, however, Kirsch's research -- a thorough analysis of decades of Food and Drug Administration data -- has demonstrated that what everyone knew about antidepressants was wrong. Instead of treating depression with drugs, we've been treating it with suggestion. The Emperor's New Drugs makes an overwhelming case that what had seemed a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: he offers a path society can follow so that we stop popping pills and start proper treatment for depression. |
Otras ediciones - Ver todo
The Emperor's New Drugs: Exploding the Antidepressant Myth Irving Kirsch Vista previa restringida - 2010 |
The Emperor's New Drugs: Exploding the Antidepressant Myth Irving Kirsch Vista previa restringida - 2010 |
The Emperor's New Drugs: Exploding the Antidepressant Myth Irving Kirsch No hay ninguna vista previa disponible - 2009 |
Términos y frases comunes
active drug active placebos analyses anti antidepres antidepressant drugs antidepressant medication assess benefit better than placebos brain activity changes Chapter chemical imbalance chemical-imbalance theory citalopram classical conditioning clinical depression clinical practice clinical significance clinical trials clinical-trial cognitive Cognitive Therapy colleagues concluded conditioning David David Healy depres difference between drug doctors dopamine dose drug and placebo drug companies drug effect drug–placebo difference effects of antidepressants evaluate evidence exercise expect experience feel given a placebo GlaxoSmithKline Hamilton scale hypothesis imipramine improvement iproniazid Irving Kirsch Kaptchuk Medicine ment meta-analysis monoamine nausea neurotransmitters nocebo effect norepinephrine pain placebo effect placebo group placebo pills placebo treatment placebo-controlled prescribed produce Prozac psychotherapy published real drug regulatory agencies relapse reported researchers reserpine reuptake serotonin Seroxat showed side effects sion SSRIs St John’s wort STAR*D trial studies subjects sugar pill symptoms therapeutic relationship therapy tianeptine tion tive told treated treatment of depression